Qrxpharma

Qrxpharma (QRX)

Stock Code

QRX

Stock Exchange

ax
QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain management and central nervous system (CNS) disorders. Based on a business strategy to expand the clinical utility and commercial value of marketed and/or existing compounds, QRxPharma’s product portfolio includes both late and early stage clinical drug candidates with well-defined paths to regulatory approval and sales.

QRxPharma Announces Partnership with Actavis for MoxDuo


After dropping in the recent days, QRxPharma (QRX) shares bounces back up by 10 per cent after it announced its partnership agreement with Actavis Group in launching its acute pain drug MoxDuo. With the final detail of the agreement still to be written and the US Food and Drug Association approval still on hold, QRxPharma has already received a non-refundable $6 million downpayment from Actavis.

QRxPharma Dividends

18 October, 2010 - 01:13

Examine the dividend records for QRxPharma. Dividends are payments made by a corporation to its shareholder members. It is the portion of corporate profits paid out to stockholders. If Qrxpharma Ltd has declared a dividend, you may be eligible to receive QRX dividends if you own the company's stock on the ex-dividend date. Investors must have purchase the shares before the ex dividend date to be entitled to the dividend declared by the company. If you buy the stocks on or after the ex dividend date, the previous owner of the shares will receive the dividend.

Syndicate content

Recommended Websites